AMENDMENT TO THE RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN THE BRIGHAM AND WOMEN’S HOSPITAL, INC. AND AUTOIMMUNE, INC. (A5732)Research and Development Agreement • November 13th, 2003 • Autoimmune Inc • Biological products, (no disgnostic substances)
This Amendment to the Research and Development Agreement (“Amendment”) between The Brigham and Women’s Hospital, Inc. (“BWH”) and AutoImmune, Inc. (“Company”) is effective July 1, 2003. The BWH and the Company are parties to a Research and Development Agreement effective September 9, 1988, as amended and restated on July 1, 1992, April 14, 1995, July 1, 2000, July 1, 2001 and July 1, 2002 (“Agreement”), pursuant to which the BWH agreed to conduct certain scientific research in consideration of the payment of certain fees by the Company.
